Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 ‌billion rand ($124 million) in its current financial year, buoyed by surging ...

The FDA has approved Mounjaro to reduce cardiovascular risk in people with type 2 diabetes after a major trial found it ...

For decades, type 2 diabetes was managed with medicines that either pushed insulin higher or improved how the body used it.

Mounjaro is the first and only GIP and GLP-1 receptor agonist proven to lower heart attack, stroke or cardiovascular death risk in adults with type 2 diabetes at high ...

Mounjaro is the first and only GIP and GLP-1 receptor agonist proven to lower heart attack, stroke or cardiovascular death risk in adults with type 2 diabetes at high risk for these events – in ...

Peptide injections have become one of the biggest wellness trends in recent times. Celebrities, influencers, and social media users claim that these injections can improve muscle growth, speed up ...

Trulicity from Eli Lilly and Co. is the kind of product you notice in a clinic waiting room, where nurses quietly line up the slim injection pens next to glucose meters and paper charts. The ...

Eli Lilly has disclosed in a civil lawsuit filed in federal court on Tuesday that a rebate fraud scheme cost it more than $200 million. The company alleges several bishops and a leader of the Church ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices they ...